We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$650M
AUM Growth
-$107M
Cap. Flow
-$73.7M
Cap. Flow %
-11.34%
Top 10 Hldgs %
28.5%
Holding
529
New
249
Increased
8
Reduced
22
Closed
155

Top Buys

Rank Stock Value
1
BEAM icon
Beam Therapeutics
BEAM
+$25.6M
2
PSFE icon
Paysafe
PSFE
+$12.2M
3
VIEW
View, Inc. Class A Common Stock
VIEW
+$11.9M
4
OUST icon
Ouster
OUST
+$9.91M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$8.09M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$53.1M
2
SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
+$27M
3
QTRX icon
Quanterix
QTRX
+$20.3M
4
SPRU icon
Spruce Power Holding Corp
SPRU
+$14.9M
5
SNRHU
Senior Connect Acquisition Corp. I Unit
SNRHU
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Financials 11.86%
3 Technology 7.97%
4 Industrials 4.89%
5 Communication Services 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADPT icon
376
Adaptive Biotechnologies
ADPT
$4.05B
– –
-30,000
Closed -$1.77M
ARVN icon
377
Arvinas
ARVN
$588M
– –
-30,000
Closed -$2.55M
AVO icon
378
Mission Produce
AVO
$1.16B
– –
-40,000
Closed -$602K
AVPT icon
379
AvePoint
AVPT
$2.75B
– –
-200,000
Closed -$3M
AVTR icon
380
Avantor
AVTR
$9.29B
– –
-253,499
Closed -$7.14M
BCAB icon
381
BioAtla
BCAB
$5.76M
– –
-400
Closed -$680K
BDSX icon
382
Biodesix
BDSX
$262M
– –
-5,299
Closed -$2.14M
SRTA
383
Strata Critical Medical Inc
SRTA
$525M
– –
-275,000
Closed -$3.05M
BLDP
384
Ballard Power Systems
BLDP
$769M
– –
-25,000
Closed -$585K
BNR
385
Burning Rock Biotech
BNR
$115M
– –
-8,000
Closed -$1.85M
BURU
386
DELISTED
NUBURU INC
BURU
– –
-501
Closed -$1.04M
CDXS icon
387
Codexis
CDXS
$161M
– –
-125,000
Closed -$2.73M
CSTL icon
388
Castle Biosciences
CSTL
$988M
– –
-25,000
Closed -$1.68M
ETWO
389
DELISTED
E2open Parent Holdings
ETWO
– –
-124,997
Closed -$1.35M
EVGO icon
390
EVgo
EVGO
$500M
– –
-149,998
Closed -$1.61M
FDMT icon
391
4D Molecular Therapeutics
FDMT
$582M
– –
-10,000
Closed -$415K
FISV
392
Fiserv Inc
FISV
$27.8B
– –
-31,000
Closed -$3.53M
GAN
393
DELISTED
GAN Ltd
GAN
– –
-50,000
Closed -$1.01M
GBTG icon
394
American Express Global Business Travel
GBTG
$4.94B
– –
-199,992
Closed -$2.08M
GH icon
395
Guardant Health
GH
$22.4B
– –
-35,000
Closed -$4.51M
DMRA
396
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.82B
– –
-3,367
Closed -$1.05M
GWH icon
397
ESS Tech
GWH
$17.1M
– –
-16,666
Closed -$2.52M
HOOK
398
DELISTED
HOOKIPA Pharma
HOOK
– –
-9,000
Closed -$998K
HYFM icon
399
Hydrofarm Holdings
HYFM
$9.29M
– –
-1,772
Closed -$932K
HYLN icon
400
Hyliion Holdings
HYLN
$701M
– –
-300,000
Closed -$4.94M
14 15
16
17 18

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Monashee Investment Management held 529 positions worth $650M, down 14% from $757M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Monashee Investment Management withdrew a net $73.7M in Q1 2021, closing 155 positions and reducing 22 holdings. Its most notable exit was Sigilon Therapeutics, Inc. Common Stock, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Financials and Technology.

Against the trend, Monashee Investment Management opened a new position in Beam Therapeutics worth $21.5M.

  • Monashee Investment Management's largest Q1 2021 buy was Beam Therapeutics: 268,820 shares worth $21.5M.
  • Monashee Investment Management added most to View, Inc. Class A Common Stock in Q1 2021, an estimated $11.9M increase.
  • Monashee Investment Management's biggest Q1 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $53.1M.
  • Monashee Investment Management fully exited Sigilon Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $27M.
  • Monashee Investment Management's ten largest holdings make up 28% of its $650M portfolio in Q1 2021.
  • Monashee Investment Management opened 249 new positions and closed 155 in Q1 2021.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $650M.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.